Positron emission tomography imaging in the thorax.
Published
Journal Article (Review)
Positron emission tomography imaging has proven valuable in the evaluation and management of thoracic abnormalities. It is more accurate than CT or MR imaging in characterizing indeterminate focal abnormal pulmonary opacities, staging lung cancer, and assessing the therapeutic response. PET imaging in lung cancer also appears to be cost-effective, particularly with whole-body studies. The metabolic and physiologic abnormalities used in FDG-PET imaging, rather than conventional anatomic or morphologic characteristics, provide an invaluable model for the future of tumor imaging.
Full Text
Duke Authors
Cited Authors
- Erasmus, JJ; Patz, EF
Published Date
- December 1999
Published In
Volume / Issue
- 20 / 4
Start / End Page
- 715 - 724
PubMed ID
- 10587793
Pubmed Central ID
- 10587793
International Standard Serial Number (ISSN)
- 0272-5231
Digital Object Identifier (DOI)
- 10.1016/s0272-5231(05)70250-1
Language
- eng
Conference Location
- United States